Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Azad

Showing results (111-120 of 199) with videos related to

Pageof 20
Sort By:
Cancer Chemotherapy and Pharmacology|July 25, 2016
A phase 1 dose-escalation study of NEO-102 in patients with refractory colon and pancreatic cancerMuhammad S Beg, Nilofer S Azad, Sandip P Patel, et al.
Small (Weinheim an Der Bergstrasse, Germany)|June 21, 2023
Water/Vapor Assisted Fabrication of Large-Area Superprotonic Conductive Covalent Organic Framework MembranesNiaz Ali Khan, Mengying Luo, Xinlin Zha, et al.
Radiation Oncology (London, England)|August 21, 2019
Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinomaAngela Y Jia, Amol Narang, Bashar Safar, et al.
NPJ Precision Oncology|November 19, 2025
Profiling ADC targets in cholangiocarcinoma: implications for therapeutic developmentMari Nakazawa, Waqar Arif, Ezra Baraban, et al.
Cancer|October 10, 2013
Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastasesGeorgios Karagkounis, Michael S Torbenson, Hubert D Daniel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 16, 2016
Soluble Adhesion Molecules During Ex Vivo Lung Perfusion Are Associated With Posttransplant Primary Graft DysfunctionK Hashimoto, M Cypel, H Kim, et al.
The Oncologist|August 16, 2022
Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017Milind Javle, Sunyoung Lee, Nilofer S Azad, et al.
British Journal of Cancer|January 10, 2018
The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinomaRachna T Shroff, Mark Yarchoan, Ashley O'Connor, et al.
British Journal of Cancer|April 26, 2017
The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinomaRachna T Shroff, Mark Yarchoan, Ashley O'Connor, et al.
JCI Insight|May 8, 2020
Neoantigen-based EpiGVAX vaccine initiates antitumor immunity in colorectal cancerVictoria M Kim, Xingyi Pan, Kevin C Soares, et al.
Pageof 20

Showing results (111-120 of 199) with videos related to

Sort By:
Pageof 20
Cancer Chemotherapy and Pharmacology|July 25, 2016
A phase 1 dose-escalation study of NEO-102 in patients with refractory colon and pancreatic cancerMuhammad S Beg, Nilofer S Azad, Sandip P Patel, et al.
Small (Weinheim an Der Bergstrasse, Germany)|June 21, 2023
Water/Vapor Assisted Fabrication of Large-Area Superprotonic Conductive Covalent Organic Framework MembranesNiaz Ali Khan, Mengying Luo, Xinlin Zha, et al.
Radiation Oncology (London, England)|August 21, 2019
Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinomaAngela Y Jia, Amol Narang, Bashar Safar, et al.
NPJ Precision Oncology|November 19, 2025
Profiling ADC targets in cholangiocarcinoma: implications for therapeutic developmentMari Nakazawa, Waqar Arif, Ezra Baraban, et al.
Cancer|October 10, 2013
Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastasesGeorgios Karagkounis, Michael S Torbenson, Hubert D Daniel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 16, 2016
Soluble Adhesion Molecules During Ex Vivo Lung Perfusion Are Associated With Posttransplant Primary Graft DysfunctionK Hashimoto, M Cypel, H Kim, et al.
The Oncologist|August 16, 2022
Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017Milind Javle, Sunyoung Lee, Nilofer S Azad, et al.
British Journal of Cancer|January 10, 2018
The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinomaRachna T Shroff, Mark Yarchoan, Ashley O'Connor, et al.
British Journal of Cancer|April 26, 2017
The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinomaRachna T Shroff, Mark Yarchoan, Ashley O'Connor, et al.
JCI Insight|May 8, 2020
Neoantigen-based EpiGVAX vaccine initiates antitumor immunity in colorectal cancerVictoria M Kim, Xingyi Pan, Kevin C Soares, et al.
Pageof 20